DEXAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexair, and what generic alternatives are available?
Dexair is a drug marketed by Pharmafair and is included in two NDAs.
The generic ingredient in DEXAIR is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexair
A generic version of DEXAIR was approved as dexamethasone sodium phosphate by HIKMA on September 7th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXAIR?
- What are the global sales for DEXAIR?
- What is Average Wholesale Price for DEXAIR?
Summary for DEXAIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Patent Applications: | 5,940 |
| DailyMed Link: | DEXAIR at DailyMed |
US Patents and Regulatory Information for DEXAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | DEXAIR | dexamethasone sodium phosphate | OINTMENT;OPHTHALMIC | 088071-001 | Dec 28, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmafair | DEXAIR | dexamethasone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 088433-001 | Dec 15, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
